GT Biopharma, Inc. v. Empery Asset Master Ltd. et al: Complaint

Complaint in GT Biopharma, Inc. v. Empery Asset Master Ltd., Empery Tax Efficient, LP, Empery Tax Efficient II, LP, and Alto Opportunity Master Fund, SPC – Segregated Master Portfolio B at the U. S. District Court for the Southern District of New York.

- You’re only seeing part of this content
  
  To view the entire article or download the document, subscribe today.
  
  – Offshore Courts: 29,000+ court cases (Bahamas, Bermuda, BVI, Cayman Islands)
  – Investigative Articles: 4,500+ in-depth articles, including fraud exposés
  – MLATs – Criminal: 1,400+ MLATs on global criminal investigations
  – Ch. 15 – Insolvencies: Monitored daily
  – Foreign Discovery: Applications for foreign discovery filed in the USA, monitored daily
  – Regulatory Actions: Global regulatory actions, fines, and bans, monitored daily
  – And More: Criminal indictments, extraditions, winding-up petitions, and more
  
  Unlimited access for less than $3/day.
  
  Cancel anytime.
  
  SUBSCRIBE
- SIGN IN
  
  Forgot your password?

Pages: 374

Date: August 01, 2018

Defendants/Respondents: Empery Asset Master Ltd., Empery Tax Efficient, LP, Empery Tax Efficient II, LP, Alto Opportunity Master Fund, SPC - Segregated Master Portfolio B

Plaintiffs/Applicants: GT Biopharma, Inc.

Case Number: Xx Xx Xx

Topic: Investment

Allegation: Fraud

Topics

Keywords

Alto Opportunity Master Fund, SPC - Segregated Master Portfolio B Anthony Cataldo Ayrton Capital LLC Empery Asset Master Ltd. Empery Tax Efficient II, LP

Empery Tax Efficient, LP GT Biopharma GT Biopharma, Inc. Karen Moraleda Northland Securities, Inc. Oppenheimer & Co., Inc. Ryan LaneRaymond Urbanski Shawn Cross Steven Weldon Vertical Group Waqas Khatri

[ 11 more... ] [ top 5 ]

BECOME A SUBSCRIBER

Daily red flags in high-value international finance

Unlimited access. No contracts. Cancel anytime.